Fatta B. Nahab M.D.
Title
Cited by
Cited by
Year
Genome‐Wide Association Study Confirms SNPs in SNCA and the MAPT Region as Common Risk Factors for Parkinson Disease
TL Edwards, WK Scott, C Almonte, A Burt, EH Powell, GW Beecham, ...
Annals of human genetics 74 (2), 97-109, 2010
4952010
Technology in Parkinson's disease: challenges and opportunities
AJ Espay, P Bonato, FB Nahab, W Maetzler, JM Dean, J Klucken, ...
Movement Disorders 31 (9), 1272-1282, 2016
3712016
The neural processes underlying self-agency
FB Nahab, P Kundu, C Gallea, J Kakareka, R Pursley, T Pohida, N Miletta, ...
Cerebral cortex 21 (1), 48-55, 2011
1612011
Validation of digital spiral analysis as outcome parameter for clinical trials in essential tremor
D Haubenberger, D Kalowitz, FB Nahab, C Toro, D Ippolito, ...
Movement Disorders 26 (11), 2073-2080, 2011
822011
Contagious yawning and the frontal lobe: an fMRI study
FB Nahab, N Hattori, ZS Saad, M Hallett
Human brain mapping 30 (5), 1744-1751, 2009
802009
C9ORF72 Intermediate Repeat Copies Are a Significant Risk Factor for Parkinson Disease
K Nuytemans, G Bademci, MM Kohli, GW Beecham, L Wang, JI Young, ...
Annals of human genetics 77 (5), 351-363, 2013
712013
Dystonia treatment: Patterns of medication use in an international cohort
SP Richardson, AR Wegele, B Skipper, A Deligtisch, HA Jinnah, ...
Neurology 88 (6), 543-550, 2017
392017
Whole‐Brain Proton MR Spectroscopic Imaging in Parkinson's Disease
BE Levin, HL Katzen, A Maudsley, J Post, C Myerson, V Govind, F Nahab, ...
Journal of Neuroimaging 24 (1), 39-44, 2014
372014
Role of the Personal KinetiGraph in the routine clinical assessment of Parkinson’s disease: recommendations from an expert panel
R Pahwa, SH Isaacson, D Torres-Russotto, FB Nahab, PM Lynch, ...
Expert review of neurotherapeutics 18 (8), 669-680, 2018
342018
Clinical and demographic characteristics related to onset site and spread of cervical dystonia
SA Norris, HA Jinnah, AJ Espay, C Klein, N Brüggemann, RL Barbano, ...
Movement Disorders 31 (12), 1874-1882, 2016
332016
Essential tremor, deceptively simple…
FB Nahab, E Peckham, M Hallett
Practical neurology 7 (4), 222-233, 2007
332007
Clinical and genetic features of cervical dystonia in a large multicenter cohort
MS LeDoux, SR Vemula, J Xiao, MM Thompson, JS Perlmutter, LJ Wright, ...
Neurology Genetics 2 (3), 2016
322016
Brain networks responsible for sense of agency: an EEG study
SY Kang, CH Im, M Shim, FB Nahab, J Park, DW Kim, J Kakareka, ...
PloS one 10 (8), e0135261, 2015
322015
Impaired sense of agency in functional movement disorders: an fMRI study
FB Nahab, P Kundu, C Maurer, Q Shen, M Hallett
PloS one 12 (4), e0172502, 2017
312017
Octanoic acid in alcohol-responsive essential tremor: a randomized controlled study
D Haubenberger, G McCrossin, C Lungu, E Considine, C Toro, FB Nahab, ...
Neurology 80 (10), 933-940, 2013
312013
An open-label, single-dose, crossover study of the pharmacokinetics and metabolism of two oral formulations of 1-octanol in patients with essential tremor
FB Nahab, L Wittevrongel, D Ippolito, C Toro, GJ Grimes, J Starling, ...
Neurotherapeutics 8 (4), 753-762, 2011
272011
Multi-modal hallucinations and cognitive function in Parkinson’s disease
H Katzen, C Myerson, S Papapetropoulos, F Nahab, B Gallo, B Levin
Dementia and geriatric cognitive disorders 30 (1), 51-56, 2010
232010
Double-blind, placebo-controlled, pilot trial of botulinum toxin A in restless legs syndrome
FB Nahab, EL Peckham, M Hallett
Neurology 71 (12), 950-951, 2008
232008
Mortality in patients with Parkinson disease psychosis receiving pimavanserin and quetiapine
GM Moreno, R Gandhi, SL Lessig, B Wright, I Litvan, FB Nahab
Neurology 91 (17), 797-799, 2018
192018
Current Role of fMRI in diagnosis of movement disorders
FB Nahab, M Hallett
Neuroimaging Clinics of North America 20 (1), 103, 2010
182010
The system can't perform the operation now. Try again later.
Articles 1–20